FdaApplication

ANDA 215739

Back to search

Identifiers

Properties

PropertyValue
applicant_namePRINSTON PHARMACEUTICAL INC
application_typeANDA
approval_date2024-04-25

Products (2)

ProductActive ingredientStrengthDosage form
SAFINAMIDE MESYLATESAFINAMIDE MESYLATEEQ 50MG BASETABLET;ORAL
SAFINAMIDE MESYLATESAFINAMIDE MESYLATEEQ 100MG BASETABLET;ORAL

2 products